Otros idiomas Shanghai Kehua Bio-Engineering Co.,Ltd

Acciones

002022

CNE000001KC9

Precio de cierre Shenzhen S.E. Otros sitios de cotización 00:00:00 23/05/2024			Varia. Cinco días.	Varia. 1 de enero.
6,88 ^CNY	-2,55 %		-4,97 %	-39,54 %

28/04	Shanghai Kehua Bio-Engineering Co.,Ltd presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
22/03	Shanghai Kehua Bio-Engineering Co.,Ltd informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Kehua Bio-Engineering Gets Registration Certificates for Two Devices	15/04
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	02/04
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections	21/03
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit	05/03
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.	29/02
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit	19/02
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) agreed to acquire 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd. for CNY 514.3 million.	12/01
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	02/01
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.	29/10/23
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.	27/10/23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit	11/10/23
Shanghai Kehua Bio-Engineering Co.,Ltd(XSEC:002022) added to S&P Global BMI Index	18/09/23
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit	14/08/23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments	29/06/23
Kehua Bio-Engineering Registers Diagnostic Reagent	22/06/23
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023	28/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Shanghai Kehua Bio-Engineering Co.,Ltd

Acciones

002022

CNE000001KC9

Otros idiomas

Filtros